Skip to main content
. 2000 Aug;100(4):502–509. doi: 10.1046/j.1365-2567.2000.00064.x

Table 1.

Expression of monocyte-differentiation antigens on U937 cells before and after treatment with transforming growth factor-β1 and 1,25-(OH)2 vitamin D3 (TGF-β1/D3)

Mean fluorescence intensities

Control TGF-β1/D3
Background (FITC) 3·0 ± 0·4 3·2 ± 0·8
IgG 2·7 ± 0·2 2·9 ± 0·3
CD11c 5·3 ± 0·2 6·6 ± 0·2*
CD14 3·0 ± 0·2 15·5 ± 2·0*
CD11b 13·5 ± 0·8 101·3 ± 12·4*
CD18 115·9 ± 3·3 296·7 ± 11·4*
*

P < 0·05 compared with control U937 cells.

Each value represents mean ± SEM of three to four experiments. The mean fluorescence value of the cell population was determined by measuring the fluorescence intensity of 10 000 cells.

FITC, fluorescein isothiocyanate.